Capital Fund Management S.A. Organon & Co. Call Options Transaction History

Capital Fund Management S.A.

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 13, 2024	SELL	$18.65 - $23.03 $42,895 - $52,969	-2,300 Reduced 0.61%	372,000 $7.12 Million
Q2 2024 Aug 13, 2024	SELL	$17.45 - $21.96 $3.24 Million - $4.07 Million	-185,400 Reduced 33.12%	374,300 $7.75 Million
Q1 2024 May 15, 2024	BUY	$13.78 - $18.8 $795,106 - $1.08 Million	57,700 Added 11.49%	559,700 $10.5 Million
Q4 2023 Feb 14, 2024	BUY	$10.95 - $17.32 $2.94 Million - $4.64 Million	268,100 Added 114.62%	502,000 $7.24 Million
Q3 2023 Nov 14, 2023	BUY	$16.59 - $23.77 $560,742 - $803,426	33,800 Added 16.89%	233,900 $4.06 Million
Q2 2023 Aug 14, 2023	BUY	$19.27 - $24.63 $3.38 Million - $4.32 Million	175,200 Added 703.61%	200,100 $4.16 Million
Q1 2023 May 15, 2023	BUY	$21.42 - $32.08 $533,358 - $798,792	24,900 New	24,900 $585,000

793

192M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.71B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Capital Fund Management S.A., based on Form 13F filings with the SEC.

Stay updated on Capital Fund Management S.A. with notifications on news.